Details Basic Details Approval Date Tuesday, November 22, 2022 Original Posting Date Tuesday, January 23, 2024 Health Outcome(s) adverse pregnancy and fetal outcomes, cytokine release syndrome, hypersensitivity reactions, lymphoproliferative disorder, malignancy, serious infection Regulatory Link(s) (2) FDA Approval Package ARIA Memo